Previous investigations have revealed unaltered CSF concentrations of T‐tau and P‐tau in PD and PSP56 as well as lowered concentrations of T‐tau and P‐tau in PSP,57 compared to controls. The gene discussed is MAPT; the disease is Parkinson disease.